Skip to main content

Globe Unlimited subscribers now can access quantitative reports for 5,000 recommended North American stocks from ValuEngine.

The recommendations are based on the proprietary ValuEngine one-year forecast return model for each individual equity, which uses advanced market valuation and price forecasting technologies.

ValuEngine’s Five-Engine rating stocks have an average annual return of 11.62 per cent since 2002. The predictive variables used in Valuengine’s forecast model include both proprietary and well-established variables derived from credible financial studies and publications.

Story continues below advertisement

ValuEngine reports update daily and are exclusive to Globe and Mail subscribers. They are located in the centre of all stock profile pages, appearing alongside StockReports+ (Thomson Reuters) and StockCalc (Patchell Brook Equity Analytics Inc.)

We hope you find ongoing enhancements to our investing tools useful. We welcome your comments on this article page, or by reaching out to me directly, at mshaye@globeandmail.com.

Michael Shaye, Senior Product Manager, Financial Products

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies